Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.

Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice

Open access

Abstract

Male C57BL/6J mice raised on high fat diet (HFD) become prediabetic and develop insulin resistance and sensory neuropathy. The same mice given low doses of streptozotocin are a model of type 2 diabetes (T2D), developing hyperglycemia, severe insulin resistance and diabetic peripheral neuropathy involving sensory and motor neurons. Because of suggestions that increased NAD + metabolism might address glycemic control and be neuroprotective, we treated prediabetic and T2D mice with nicotinamide riboside (NR) added to HFD. NR improved glucose tolerance, reduced weight gain, liver damage and the development of hepatic steatosis in prediabetic mice while protecting against sensory neuropathy. In T2D mice, NR greatly reduced non-fasting and fasting blood glucose, weight gain and hepatic steatosis while protecting against diabetic neuropathy. The neuroprotective effect of NR could not be explained by glycemic control alone. Corneal confocal microscopy was the most sensitive measure of neurodegeneration. This assay allowed detection of the protective effect of NR on small nerve structures in living mice. Quantitative metabolomics established that hepatic NADP + and NADPH levels were significantly degraded in prediabetes and T2D but were largely protected when mice were supplemented with NR. The data justify testing of NR in human models of obesity, T2D and associated neuropathies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep26933

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 NR Improves Metabolic Parameters in PD and T2D. (a) NR reduces weight gain on HFD independent of STZ. (b–d) NR reduces hepatic steatosis in the PD and T2D models. NR lowers circulating cholesterol (e) and circulating alanine aminotransferase (f) in PD. In T2D, NR tends to lower HbA1C (g) and depresses nonfasting glucose (h). NR depresses fasting glucose in both models (i). NR improves GTT in PD (j). Statistics were by two-way ANOVA. n = 10. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 1 NR Improves Metabolic Parameters in PD and T2D. (a) NR reduces weight gain on HFD independent of STZ. (b–d) NR reduces hepatic steatosis in the PD and T2D models. NR lowers circulating cholesterol (e) and circulating alanine aminotransferase (f) in PD. In T2D, NR tends to lower HbA1C (g) and depresses nonfasting glucose (h). NR depresses fasting glucose in both models (i). NR improves GTT in PD (j). Statistics were by two-way ANOVA. n = 10. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Figure 2 NR Opposes PDPN and T2DPN. (a) NR protects against a decline in MNCV in T2D. (b) NR protects against declines in SNCV in PD and T2D. (c) NR protects against loss of thermal sensitivity in both models. (d,e) NR improves INFD on NC and in both disease models. Statistics were by two-way ANOVA. n = 10. **P < 0.01; ***P < 0.001.
Figure 2 NR Opposes PDPN and T2DPN. (a) NR protects against a decline in MNCV in T2D. (b) NR protects against declines in SNCV in PD and T2D. (c) NR protects against loss of thermal sensitivity in both models. (d,e) NR improves INFD on NC and in both disease models. Statistics were by two-way ANOVA. n = 10. **P < 0.01; ***P < 0.001.CC BY · PubMed Central
Figure 3 Neuroprotective Activity of NR in DPN Can be Monitored by Corneal Confocal Microscopy. (a,b) CCM is a sensitized assay for PD and T2D nerve loss. (c) and (d) By post-mortem class III β-tubulin staining, NR protects against corneal sub-epithelial nerve loss in T2D. Statistics were by two-way ANOVA. n = 10. *P < 0.05; **P < 0.01; ***P < 0.001.
Figure 3 Neuroprotective Activity of NR in DPN Can be Monitored by Corneal Confocal Microscopy. (a,b) CCM is a sensitized assay for PD and T2D nerve loss. (c) and (d) By post-mortem class III β-tubulin staining, NR protects against corneal sub-epithelial nerve loss in T2D. Statistics were by two-way ANOVA. n = 10. *P < 0.05; **P < 0.01; ***P < 0.001.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 36 references

Cited by

See all 301

Metadata

Authors
Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C.
Affiliations
  • University of Iowa (US)
  • Iowa City VA Health Care System (US)
Corresponding author
Brenner, Charles
Venue
Scientific Reports
Published
2016-05-27
Volume
6
Issue
1
Pages
26933-26933
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2400466055
Cited by
301
References
36
Citations by year
2026: 11 · 2025: 21 · 2024: 29 · 2023: 26 · 2022: 55 · 2021: 42 · 2020: 33 · 2019: 34 · 2018: 25 · 2017: 20 · 2016: 4
FWCI
15.94
Type
journal article
Language
en
Open access
Licence
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion, other-oa)
Funders
  • U.S. Department of Veterans Affairs (I01 BX001680, BX001680-01, BX001680, RX000889, C9251-C, RX000889-01, I01 RX000889)
  • Roy J. Carver Charitable Trust
  • Fraternal Order of Eagles
  • National Institutes of Health (BX001680)
  • National Institute on Alcohol Abuse and Alcoholism (R21AA022371)
  • National Institute of General Medical Sciences (T32GM008629)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081147)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
Keywords
nicotinamide riboside, type 2 diabetes, diabetic neuropathy, NAD+ metabolism, insulin resistance, high-fat diet, streptozotocin-induced diabetes, hepatic steatosis, glucose tolerance, sensory neuropathy, corneal confocal microscopy, NADPH, neuroprotection, obesity
MeSH terms
Animals, Blood Glucose, Cornea, Diabetes Mellitus, Experimental, Diabetic Neuropathies, Hypoglycemic Agents, Insulin, Insulin Resistance, Liver, Male, Mice, Inbred C57BL, Niacinamide, Obesity, Prediabetic State, Pyridinium Compounds, Streptozocin, Mice, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. https://app.cochat.ai/papers/10.1038/srep26933
The paper
Trammell, S. A. J., Weidemann, B. J., Chadda, A., Yorek, M. S., Holmes, A., Coppey, L. J., Obrosov, A., Kardon, R. H., Yorek, M. A., & Brenner, C. (2016). Nicotinamide Riboside Opposes Type 2 Diabetes and Neuropathy in Mice. Scientific Reports. https://doi.org/10.1038/srep26933

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.